Data, collaboration & the digital twin.
OnKommon is a company with a research spine.
OnKommon is a company with a research spine. Our commercial services generate exactly the kind of longitudinal, consented clinicogenomic data that oncology research needs — and our long-term vision, the computational digital twin, is fundamentally a research programme. We collaborate with academic and clinical researchers who share that direction.
1 · Research at OnKommon
OnKommon is a company with a research spine.
OnKommon is a company with a research spine. Our commercial services generate exactly the kind of longitudinal, consented clinicogenomic data that oncology research needs — and our long-term vision, the computational digital twin, is fundamentally a research programme. We collaborate with academic and clinical researchers who share that direction.
2 · Longitudinal ctDNA & clonal-dynamics datasets
Serial Sentinel and Clear testing produce time-series molecular data — how tumours evolve under treatment, how resistance emerges, how clonal architecture shifts. With consent and governance, these datasets are a rich substrate for studying treatment response, resistance mechanisms, and disease trajectory.
3 · Engine validation & knowledge curation
We welcome collaboration on validating and improving the OnKommon Interpretation Engine — benchmarking calls, refining oncogenicity classification, and strengthening the curated knowledge base that harmonises international evidence standards. Rigorous, published validation is how decision-support earns trust.
4 · Academic alignment
OnKommon collaborates with academic partners in systems biology and computational oncology, creating natural bridges for student projects, method development, and teaching cases grounded in real, consented, de-identified data.
5 · Publication & collaboration model
Co-designed studies with shared authorship.
Co-Designed Studies
Co-designed studies with clear data-governance and consent frameworks.
De-Identified Data Access
De-identified data access under approved protocols.
Shared Authorship
Shared authorship and transparent reporting of methods and limitations.
6 · Toward the digital twin
Every strand — comprehensive profiling, serial monitoring, functional models in the pipeline — feeds one destination: a validated computational twin of a patient's cancer that lets therapies be explored in silico before they are given. Researchers who want to help build that future are exactly who this page is for.
Propose a CollaborationTake the next step
Every OnKommon page offers three ways forward. Choose the one that fits where you are today.
Book a free Blueprint Consultation
A no-obligation conversation with our care team, arranged through KPCIRC, to map your situation and the right starting point.
Book now →Free WhatsApp guidance (Signal)
A 4-hour triage reply to your first question, at no cost.
Start WhatsApp triage →